@article{261eb4f5502f43e6a6c9c81866b5e536,
title = "Why has targeting EGFR aberrations in glioblastoma therapy had limited success?",
keywords = "Antineoplastic agents, blood-brain barrier, epidermal Growth Factor Receptor, glioblastoma, targeted therapy",
author = "Kizilbash, {Sani H.}",
note = "Funding Information: This paper was funded by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) (R01 FD-R-07288 to SHK).",
year = "2022",
doi = "10.1080/14737140.2022.2146581",
language = "English (US)",
volume = "22",
pages = "1261--1263",
journal = "Expert review of anticancer therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "12",
}